Radioluminiscent BODIPY-conjugated nanomaterials: towards the activation of PDT in deep tissue and during radiation therapy - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Communication Dans Un Congrès Année : 2019

Radioluminiscent BODIPY-conjugated nanomaterials: towards the activation of PDT in deep tissue and during radiation therapy

Carlotta Figliola
Fréderic Chaput

Résumé

Photodynamic therapy (PDT) is an anti-cancer treatment based on a photosensitizer (PS) generating cytotoxic singlet oxygen and its derivatives in situ under light irradiation. Common photosensitizers are activated by visible light, which penetrates only weakly in the tissues and, thus, limits the PDT to superficial tumors. An effective, elegant and relatively new way to activate PDT in deep tissue is the conjugation of the PS to a nanoscintillator (NS), which is able to convert X-rays to visible light exciting the PS and inducing PDT during the radiotherapy (RT)
Fichier non déposé

Dates et versions

hal-02521752 , version 1 (27-03-2020)

Identifiants

  • HAL Id : hal-02521752 , version 1

Citer

Carlotta Figliola, Fréderic Chaput, Anne-Laure Bulin, Mans Broekgaarden, Christelle Gateau, et al.. Radioluminiscent BODIPY-conjugated nanomaterials: towards the activation of PDT in deep tissue and during radiation therapy. Imaging of diagnostic and therapeutic biomarkers in Oncology, Sep 2019, Le Bono, France. ⟨hal-02521752⟩
48 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More